Sunshine Biopharma (SBFM) FCF Margin Growth (1y) (2019 - 2026)
Sunshine Biopharma (SBFM) FCF Margin Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 74.00 |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | -247.00 |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | 546.00 |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | -209.00 |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | -522.00 |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 828.00 |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | 301.00 |
| 10 | Sunshine Biopharma | 750,608.81 | -6.16 Mn | 2.18 Mn | -655.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -655.00 |
| Dec 31, 2025 | 1,773.00 |
| Sep 30, 2025 | 1,440.00 |
| Jun 30, 2025 | 4,425.00 |
| Mar 31, 2025 | 2,395.00 |
| Dec 31, 2024 | -652.00 |
| Sep 30, 2024 | -1,437.00 |
| Jun 30, 2024 | 826.00 |
| Mar 31, 2024 | -527.00 |
| Dec 31, 2023 | 3,190.00 |
| Sep 30, 2023 | 83,830.00 |
| Jun 30, 2023 | 31,381.00 |
| Mar 31, 2023 | 102,560.00 |
| Dec 31, 2022 | 30,474.00 |
| Sep 30, 2022 | 34,651.00 |
| Jun 30, 2022 | 78,867.00 |
| Mar 31, 2022 | -32,109.00 |
| Dec 31, 2021 | 114,713.00 |
| Sep 30, 2021 | -48,491.00 |
| Jun 30, 2021 | -62,889.00 |